Skip to main content

Table 2 Differences between HER2 evaluation in tumors of the upper gastrointestinal tract and breast cancer

From: HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

 

Tumors of the upper gastrointestinal tract

Breast cancer

Threshold

≥ 5 positive tumor cells of biopsies; ≥ 10% surgical specimen

≥ 10% positive tumor cells

Expression pattern

(baso)-lateral

circular